Company news
Corline Biomedical Ab (OMXSTO:CLBIO) news
Corline Biomedical Ab news releases on 6ix. Latest, May 8, 2026: Corline Biomedical Q1 Result After Financial Items At SEK -2.5 Mln
Press releases & updates
Corline Biomedical Q1 Result After Financial Items At SEK -2.5 Mln
May 8, 2026
Corline Biomedical Q4 (Review): Case intact, but sales ramp-up needed to restore market confidence
February 18, 2026
CLBIO: FDA approval, US launch, and a major 10-year deal drove a pivotal commercial breakthrough
February 17, 2026
Corline Flags Share Issue Raising About SEK 9.24 Mln
January 9, 2026
CLBIO: Breakthrough quarter with FDA approval, long-term deal, and capital raise set stage for growth
November 18, 2025
Corline Biomedical Signs 10-Year Agreement With Kardium
September 30, 2025
CLBIO: Growth depends on Kardium's US launch, with cost cuts improving results despite lower sales
August 26, 2025
CLBIO: Corline's Q1 2025 loss widens, but US market entry and strong clinical data drive optimism
May 8, 2025
CLBIO: 2024 saw heavy losses and restructuring, but Corline targets US growth with CHSTM-coated Globe®
February 17, 2025
CLBIO: Sharply reduced costs and strategic focus position Corline for growth and profitability by 2025
November 7, 2024
CLBIO: Revenue down, losses widened, but US launch and new projects drive future potential
August 23, 2024